Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.

Clinical trial NCT00835237 · COMPLETED

Trial details

NCT number: NCT00835237
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tetanus Acellular Pertussis Diphtheria Diphtheria-Tetanus-acellular Pertussis Vaccines

Start date: 2009-02-17
Primary completion: 2009-07-23
Enrollment: 1332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.